COST-EFFECTIVENESS OF QUADRIVALENT HPV VACCINATION IN FINLAND

被引：0
|
作者：
Vaananen, J. J. P. [1 ]
Herse, F. [1 ]
Korkeamaki, J. [2 ]
Parvinen, P. M. T. [1 ]
Remy, O. [3 ]
机构：
[1] Nord Healthcare Grp, Helsinki, Finland
[2] Sanofi Pasteur MSD Oy, Helsinki, Finland
[3] Sanofi Pasteur MSD, Lyon, France
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66455-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of HPV 16, 18 vaccination in Brazil
    Goldie, Sue J.
    Kim, Jane J.
    Kobus, Katie
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua
    O'Shea, Meredith K. H.
    Xavier Bosch, F.
    de Sanjose, Silvia
    Franco, Eduardo L.
    [J]. VACCINE, 2007, 25 (33) : 6257 - 6270
  • [22] The cost-effectiveness of male HPV vaccination in the United States
    Chesson, Harrell W.
    Ekwueme, Donatus U.
    Saraiya, Mona
    Dunne, Eileen F.
    Markowitz, Lauri E.
    [J]. VACCINE, 2011, 29 (46) : 8443 - 8450
  • [23] COST-EFFECTIVENESS OF INTERVENTIONS TO INCREASE HPV VACCINATION COVERAGE
    Spencer, Jennifer
    Brewer, Noel T.
    Trogdon, Justin
    Coyne-Beasley, Tamera
    Wheeler, Stephanie B.
    [J]. MEDICAL DECISION MAKING, 2020, 40 (01) : E30 - E31
  • [24] Reply letter to "Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal"
    Hadigal, Sanjay
    Colombo, Laura
    Cook, Joseph
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 933 - 934
  • [25] Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
    Quinn, Emma
    Jit, Mark
    Newall, Anthony T.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (03) : 425 - 435
  • [26] Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
    Watle, Sara Viksmoen
    Naess, Lisbeth Meyer
    Tunheim, Gro
    Caugant, Dominique A.
    Wisloff, Torbjorn
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2777 - 2787
  • [27] The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective
    Setiawan, Didik
    Luttjeboer, Jos
    Westra, Tjalke Arend
    Wilschut, Jan C.
    Suwantika, Auliya A.
    Daemen, Toos
    Atthobari, Jarir
    Wilffert, Bob
    Postma, Maarten J.
    [J]. EXPERT REVIEW OF VACCINES, 2015, 14 (04) : 589 - 604
  • [28] The potential cost-effectiveness of HPV vaccination among girls in Mongolia
    Luvsan, Munkh-Erdene
    Vodicka, Elisabeth
    Jugder, Uranbolor
    Tudev, Undarmaa
    Clark, Andy
    Groman, Devin
    Otgonbayar, Dashpagam
    Demberelsuren, Sodbayar
    LaMongtagne, D. Scott
    Pecenka, Clint
    [J]. VACCINE: X, 2022, 11
  • [29] BEYOND CERVICAL CANCER: THE COST-EFFECTIVENESS OF HPV VACCINATION IN THE NETHERLANDS
    Setiawan, D.
    Cao, Q.
    Westra, T. A.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A416 - A417
  • [30] Cost-effectiveness of extending the HPV vaccination to boys: a systematic review
    Linertova, Renata
    Guirado-Fuentes, Carmen
    Mar Medina, Javier
    Imaz-Iglesia, Inaki
    Rodriguez-Rodriguez, Leticia
    Carmona-Rodriguez, Montserrat
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2021, 75 (09): : 910 - 916
12345